Ace Therapeutics is a specialized preclinical contract research organization providing integrated research services to support pharmaceutical and biotechnology companies throughout the preclinical stage of drug development.
Our capabilities span a broad range of preclinical research areas, including in vitro and in vivo efficacy testing, disease model development, pharmacokinetics and pharmacodynamics (PK/PD), toxicology, biomarker research, and safety assessment.
Our multidisciplinary scientific team combines established preclinical models, specialized research platforms, and fit-for-purpose study designs to address diverse drug development requirements. From early-stage research and target evaluation to candidate assessment and preclinical development, we provide scientific expertise and study execution tailored to the objectives of each program.
Through integrated study design, experimental execution, and data analysis, we generate relevant preclinical data to support candidate evaluation, development decisions, and progression toward clinical development.
We provide comprehensive preclinical research for respiratory conditions, utilizing specialized respiratory models to study diseases such as asthma, COPD, and pulmonary fibrosis. Our services include efficacy testing, pharmacokinetic assessments, and inhalation delivery optimization to support targeted therapeutic development from early discovery to proof-of-concept.
Ace Therapeutics excels in preclinical research for ocular therapies, offering preclinical studies to evaluate drug action, safety, and pharmacokinetics in the eye. We focus on optimizing early-stage development through pilot studies and proof-of-concept experiments to refine formulations for targeted ocular delivery.
We provide advanced preclinical cardiovascular research using a wide range of gold standard animal models. Our services focus on optimizing drug candidates and assessing their efficacy to ensure robust and reliable research results.
Ace Therapeutics provides cutting-edge preclinical models for neurological and psychiatric diseases, supporting research from disease modeling to pharmacodynamics. Our tailored solutions are designed to accurately reflect disease progression and evaluate potential therapeutic interventions.
Ace Therapeutics provides tailored preclinical research services aligned with the scientific objectives and development requirements of each program.
From study design and model development to experimental execution and data analysis, our team supports clients in generating scientifically relevant preclinical data for informed drug development decisions.
We provide research services that support foundational studies and early-stage therapeutic research, including gene editing, vector construction, molecular and cellular assays, and omics analysis. Study approaches can be tailored to the scientific objectives and requirements of each research program.
Our drug discovery services support the evaluation and advancement of therapeutic targets and candidates. Key capabilities include target discovery and validation, compound screening, in vitro and in vivo pharmacology, and assay development.
We provide comprehensive preclinical research services to evaluate the pharmacological activity, efficacy, pharmacokinetics, biomarkers, and safety profiles of therapeutic candidates before clinical development. Our capabilities include in vitro studies, in vivo disease models, pharmacokinetic studies, and other preclinical assessments designed to generate relevant data for development decisions.
For programs progressing beyond preclinical research, we can connect clients with external clinical research organizations (CROs) through our network, based on specific project needs.
The referred CROs may have experience supporting clinical development across selected therapeutic areas. Their capabilities may broadly include:
Experience across multiple disease areas and clinical development stages, from early-phase to late-phase studies.
Involvement in a range of study types, including interventional, observational, real-world, and clinical pharmacology–related studies.
Established operational frameworks, access to clinical resources, and general experience with regulatory and quality expectations.
Introductions can be arranged upon request to enable direct engagement with relevant clinical partners. Please contact us to explore suitable clinical referral options for your program.
WHY CHOOSE US
Ace Therapeutics provides comprehensive preclinical CRO services across diverse therapeutic areas, combining scientific expertise, specialized platforms, and established preclinical models.
Our multidisciplinary team covers disease model development, efficacy evaluation, PK/PD, biomarker research, toxicology, and safety assessment, with study strategies tailored to specific research requirements.
Through integrated study design, execution, and data analysis, we generate relevant preclinical data to support candidate evaluation and informed drug development decisions.
Ace Therapeutics boasts a team of highly committed and skilled researchers dedicated to delivering innovative preclinical contract research solutions.
We provide tailored preclinical services designed to streamline your research process and advance promising concepts into actionable insights, ensuring efficient progress in drug development.
Copyright © Ace Therapeutics. All rights reserved.
↑
